Insys Therapeutics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Insys Therapeutics, Inc. inventory turnover ratio, the Insys Therapeutics, Inc.'s ability to sell and replace its inventory in the first quarter 2019, sequentially increased to 1.44 in the first quarter 2019, a new company high. Average inventory processing period, for the Insys Therapeutics in Mar 31 2019 quarter, has decreased to 253 days, compare to 384 days, in the Dec 31 2018 quarter.

Within Healthcare sector 317 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1938 in the fourth quarter 2018, to 1941.

INSY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Insys Therapeutics, Inc. Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INSY Inventory Turnover Ratio	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter	(Jun 30 2018) II. Quarter	(Mar 31 2018) I. Quarter
Y / Y Inventory Growth	-55.55 %	-50.55 %	-41.63 %	-49.96 %	-23.43 %
Y / Y Cost of Sales Growth	107.58 %	-43.09 %	-68.16 %	-8.29 %	-52.49 %
Inventory Turnover Ratio (TTM)	1.44	0.95	0.94	1.15	1.01
INSY's Total Ranking	# 1941	# 1938	# 1941	# 1941	# 2028
Average inventory processing period	254	386	389	317	361
Seq. Inventory Growth	-15.82 %	-19.96 %	7.53 %	-38.64 %	-6.36 %
Seq. Cost of Sales Growth	74.35 %	10.3 %	-33.84 %	63.16 %	-52.2 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 101
Healthcare Sector	# 318
Overall Market	# 1941

Inventory Turnover Ratio Statistics
High	Average	Low
1.44	0.85	0.57
(Mar 31 2019)		(Dec 31 2016)

INSY Company Profile >> Back to INSY Efficiency Comparisons >> Compare INSY Inventory Turnover Ratio to its Competitors

Financial Statements
Insys Therapeutics's Inventories	$ 7 Millions	Visit INSY's Balance sheet
Insys Therapeutics's Cost of Revenues TTM	$ 13 Millions	Visit INSY's Income Statement
What are INSY's Sales?		Visit INSY's Sales by Segment

Other Inventory Turnover Ratios
Insys Therapeutics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
INSY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for INSY's Competitors
Inventory Turnover Ratio for INSY's Suppliers
Inventory Turnover Ratio for INSY's Customers

You may also want to know
INSY's Sales Growth Rates	INSY's Pe Price to earnings ratio	INSY's Receivables Turnover Ratio	INSY's Stock Quote
INSY's Net Income Growth Rates	INSY's Ps Price to Sales ratio	INSY's Sales per Employee	INSY's Asset Turnover Ratio
INSY's Net Margin	INSY's Pb Price to Book ratio	INSY's Financial Strength Ratios	INSY's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2019	Inventories at quarter ending Mar 31 2019
Nuo Therapeutics Inc	5.00	$ 0.143 Millions	$ 0 Millions
Caredx Inc	4.98	$ 24.182 Millions	$ 5 Millions
Stablecoin Development Corporation	4.94	$ 1.593 Millions	$ 0 Millions
Henry Schein Inc	4.94	$ 8,890.642 Millions	$ 1,801 Millions
Endo International Plc	4.87	$ 1,619.993 Millions	$ 332 Millions
Adm Tronics Unlimited Inc	4.86	$ 1.455 Millions	$ 0 Millions
Myriad Genetics Inc	4.83	$ 164.600 Millions	$ 34 Millions
Tandem Diabetes Care Inc	4.82	$ 110.813 Millions	$ 23 Millions
Tearlab Corp	4.75	$ 9.262 Millions	$ 2 Millions
Enovis Corp	4.66	$ 2,573.046 Millions	$ 553 Millions
Strata Skin Sciences Inc	4.55	$ 12.314 Millions	$ 3 Millions
Quorum Health Corporation	4.51	$ 206.245 Millions	$ 46 Millions
Abbvie Inc	4.49	$ 7,485.000 Millions	$ 1,668 Millions
Micron Solutions Inc	4.48	$ 16.885 Millions	$ 4 Millions
United Cannabis Corp	4.47	$ 9.235 Millions	$ 2 Millions
Stereotaxis Inc	4.47	$ 5.864 Millions	$ 1 Millions
Dariohealth Corp	4.45	$ 6.109 Millions	$ 1 Millions
Standard Biotools Inc	4.38	$ 62.838 Millions	$ 14 Millions
Integrated Biopharma Inc	4.35	$ 42.850 Millions	$ 10 Millions
Remedent Inc	4.34	$ 0.486 Millions	$ 0 Millions
Conformis inc	4.32	$ 41.248 Millions	$ 10 Millions
Msa Safety Inc	4.31	$ 743.742 Millions	$ 173 Millions
Portola Pharmaceuticals inc	4.19	$ 24.895 Millions	$ 6 Millions
Kushco Holdings Inc	4.19	$ 78.627 Millions	$ 19 Millions
Integer Holdings Corporation	4.17	$ 792.438 Millions	$ 190 Millions
Cantel Medical Corp	4.12	$ 483.329 Millions	$ 117 Millions
Dynatronics Corporation	4.11	$ 44.307 Millions	$ 11 Millions
Nuvectra Corp	4.05	$ 24.226 Millions	$ 6 Millions
Aerie Pharmaceuticals Inc	4.05	$ 32.024 Millions	$ 8 Millions
Kaya Holdings Inc	4.03	$ 0.537 Millions	$ 0 Millions

Date modified: 2026-08-29T17:20:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.